Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

20
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
20
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

21
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

14
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Heart Valves01:16

Heart Valves

5.3K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
5.3K
Ventilatory Modes01:14

Ventilatory Modes

276
Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
276
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliable Flow, Cost-Effective, Comfortable: Tunneled Veno-Pulmonary Artery Extracorporeal Membrane Oxygenation Cannulation Technique.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Bleeding and Thrombosis Associated With Microaxial Flow Percutaneous Ventricular Assist Devices in Patients With Cardiogenic Shock: A Flood of Events, a Drought of Harmonized Data.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Triathlete With Repaired D-Transposition of the Great Arteries and Anterior Left Anterior Descending Coronary Artery Takeoff.

JACC. Case reports·2026
Same author

No New Green in Wasted Lands:Lessons From the LEVOECMO Trial.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Fluoroscopy-Free Axillary Impella 5.5 Implantation, Earlier Support With Just Transesophageal Echocardiography Images.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Durable Left-Ventricular Assist Device Inflow Thrombosis Following External Outflow Graft Obstruction.

JACC. Case reports·2025

Related Experiment Video

Updated: Aug 6, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Temporary Mechanical Circulatory Support: Left, Right, and Biventricular Devices.

Michael Dangl1, Michael Albosta1, Hoda Butros2

  • 1Department of Internal Medicine, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, FL, USA.

Current Cardiology Reviews
|March 15, 2023
PubMed
Summary

Temporary mechanical circulatory support (MCS) offers short-term hemodynamic assistance for various conditions, including cardiogenic shock and heart failure. Device selection depends on clinical factors and patient needs.

Keywords:
ECMOHeart failurecardiogenic shockimpellaintra-aortic balloon pumpleft ventricular assist devicemechanical circulatory support

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Related Experiment Videos

Last Updated: Aug 6, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Area of Science:

  • Cardiology
  • Medical Devices
  • Critical Care Medicine

Background:

  • Temporary mechanical circulatory support (MCS) provides crucial short-term hemodynamic support.
  • Indications have broadened beyond cardiogenic shock to include high-risk procedures and bridging therapy.

Approach:

  • This review discusses various temporary MCS devices for left, right, or biventricular support.
  • It covers indications, contraindications, complications, and hemodynamic effects.

Key Points:

  • Temporary MCS devices are vital for acute circulatory failure and as a bridge to advanced therapies.
  • Device choice involves clinical scenario, patient specifics, and institutional protocols.
  • Understanding device variations and their clinical data is essential for optimal patient management.

Conclusions:

  • Temporary mechanical circulatory support is a versatile tool in managing acute cardiovascular conditions.
  • Careful consideration of device type and patient factors optimizes outcomes.